Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 23, 2020 - Issue 3
158
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Ultrasound monitoring during first-cycle treatment with clomifene citrate: a national survey of compliance with NICE

ORCID Icon, , , &
Pages 193-199 | Received 07 Mar 2018, Accepted 31 Aug 2018, Published online: 02 Nov 2018

References

  • Bhattacharya, S., Harrild, K., Mollison, J., Wordsworth, S., Tay, C., Harrold, A., … Templeton, A. (2008). Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: Pragmatic randomised controlled trial. British Medical Journal, 337, a716. doi: 10.1136/bmj.a716.
  • Coughlan, C., Fitzgerald, J., Milne, P., & Wingfield, M. (2010). Is it safe to prescribe clomiphene citrate without ultrasound monitoring facilities?. Journal of Obstetrics and Gynaecology, 30, 393–396. doi: 10.3109/01443611003646280.
  • Cresswell, J. W., & Plano-Clark, V. (2003). Advanced mixed methods research designs. In A. Tashakkori & C. Teddlie (Eds.), Handbook of mixed methods in social and behavioural research. Thousand Oaks, CA: Sage.
  • Dickey, R. P., & Holtkamp, D. E. (1996). Development, pharmacology and clinical experience with clomiphene citrate. Human Reproduction Update, 2, 483–506. doi: 10.1093/humupd/2.6.483.
  • Flanigan, T., McFarlane, E., & Cook, S. (2008). Conducting survey research among physicians and other medical professionals: A review of current literature. In ASA Proceedings of the Section on Survey Research Methods (2008), 4136–4147. Retrieved October 8, 2018, from https://ww2.amstat.org/sections/srms/Proceedings/y2008/Files/flanigan.pdf.
  • Galazis, N., Zertalis, M., Haoula, Z., & Atiomo, W. (2011). Is ultrasound monitoring of the ovaries during ovulation induction by clomiphene citrate essential? A systematic review. Journal of Obstetrics and Gynaecology, 31, 566–571. doi: 10.3109/01443615.2011.596956.
  • Hackethal, A., Sick, C., Brueggmann, D., Tchartchian, G., Wallwiener, M., Muenstedt, K., & Tinneberg, H. R. (2010). Awareness and perception of intra-abdominal adhesions and related consequences: Survey of gynaecologists in German hospitals. European Journal of Obstetrics & Gynecology and Reproductive Biology, 150, 180–189. doi: 10.1016/j.ejogrb.2010.02.017.
  • Hughes, E., Brown, J., Collins, J. J., & Vanderkerchove, P. (2010). Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systematic Reviews, 2010, CD000057. doi: 10.1002/14651858.CD000057.pub2.
  • Kellerman, S. E., & Herold, J. (2001). Physician response to surveys: A review of the literature. American Journal of Preventive Medicine, 20, 61–67. doi: org/10.1016/S0749-3797(00)00258-0.
  • Legro, R. S. (2016). Ovulation induction in polycystic ovary syndrome: Current options. Best Practice and Research: Clinical Obstetrics and Gynaecology, 37, 152–159. doi: 10.1016/j.bpobgyn.2016.08.001.
  • McDowell, S., Kroon, B., & Yazdani, A. (2013). Clomiphene ovulation induction and higher-order multiple pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 53, 395–398. doi: 10.1111/ajo.12106.
  • Mikkelson, T. J., Kroboth, P. D., Cameron, W. J., Dittert, L. W., Chungi, V., & Manberg, P. J. (1986). Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertility and Sterility, 46, 392–396. doi: 10.1016/S0015-0282(16)49574-9.
  • Nandi, A., Gudi, A., Shah, A., & Homburg, R. (2015). An online survey of specialists’ opinion on first line management options for unexplained subfertility. Human Fertility, 18, 48–53. doi: 10.3109/14647273.2014.948081.
  • National Institute for Clinical Excellence. (2004). Fertility: Assessment and treatment for people with fertility problems. London: Author.
  • National Institute for Health and Care Excellence. (2013). Fertility problems: Assessment and treatment (CG156). London: Author.
  • Office for National Statistics. (2017). Birth characteristics in England and Wales: 2016. London: Author.
  • OpenPrescribing.net. (2018). Clomifene citrate (0605010G0). Retrieved July 17, 2018, from https://openprescribing.net/chemical/0605010G0/.
  • Royal College of Obstetricians and Gynaecologists. (1998). The Management of infertility in secondary care. London: RCOG Press.
  • Stanford, J. B., Parnell, T. A., & Boyle, P. C. (2008). Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. Journal of the American Board of Family Medicine, 21, 375–384. doi: 10.3122/jabfm.2008.05.070239.
  • Wallach, E. E., & Adashi, E. Y. (1984). Clomiphene citrate: Mechanism(s) and site(s) of action – A hypothesis revisited. Fertility and Sterility, 42, 331–334. doi: 10.1016/S0015-0282(16)48069-6.
  • Weller, A., Daniel, S., Koren, G., Lunenfeld, E., & Levy, A. (2017). The fetal safety of clomiphene citrate: A population-based retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 124, 1664–1670. doi: 10.1111/1471-0528.14651.
  • Wilkes, S., Chinn, D. J., Murdoch, A., & Rubin, G. (2009). Epidemiology and management of infertility: A population-based study in UK primary care. Family Practice, 26, 269–274. doi: 10.1093/fampra/cmp029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.